CYCN
Cyclerion Therapeutics Inc
NASDAQ: CYCN · HEALTHCARE · BIOTECHNOLOGY
$3.31
-0.30% today
Updated 2026-04-30
Market cap
$12.73M
P/E ratio
—
P/S ratio
6.14x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$1 – $8
Volume
5.6M
Cyclerion Therapeutics Inc (CYCN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-49.87M | $-81.22M | $-97.50M | $-102.22M | $-72.49M | $-36.52M | $-40.61M | $-21.25M | $-4.33M | $-3.31M |
| Capital expenditures | $1.45M | $1.40M | $3.44M | $6.89M | $1.52M | $7000.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $9.49M | $12.43M | $19.63M | $14.99M | $9.61M | $6.25M | $1.07M | $625000.00 | $441000.00 |
| Free cash flow | $-51.32M | $-82.62M | $-100.94M | $-109.10M | $-74.01M | $-36.52M | $-40.61M | $-21.25M | $-4.33M | $-3.31M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $102.64M | $-44.38M | — | — | — | — | — |